financetom
Business
financetom
/
Business
/
With low discretionary spends, expect muted demand and cautious outlook for next few quarters: Arvind Ltd
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
With low discretionary spends, expect muted demand and cautious outlook for next few quarters: Arvind Ltd
May 19, 2023 8:56 AM

"We delivered a decent performance in a difficult market. FY23 was challenging due to inflation in some of our key markets" Punit Lalbhai, Arvind Ltd said in an interaction with CNBC-TV18 on May 19. He adds that discretionary spending is low and inventories had piled up last year. However, these inventories are now reducing. Lalbhai said he expects a muted demand and has a cautious outlook for next few quarters. "The traditional textile business is under pressure".

Share Market Live

NSE

Arvind Ltd, on May 18, declared results for the fourth quarter of financial year 2022-23. Largely led by weak segmental performance in textiles, Arvind Ltd's consolidated revenues declined 15 percent to Rs 1,881 crore, while gross profit margins fell to 50 percent versus 52 percent in the same quarter of last year. This was driven by lower price realisation and volumes. Earnings before interest, tax, depreciation and amortisation (EBITDA) fell 20 percent to Rs 191 crore, while EBITDA margin was 70 bps lower at 10.1 percent versus 10.8 percent in corresponding quarter of last year. Net profits improved 3 percent to Rs 92 crore, led by 61 percent lower tax expenses in the fourth quarter.

The textile segment, which contributes majority part of of Arvind Ltd's top line, witnessed its revenues declining 22 percent to Rs 1,431 crore, while margins lowered 250 bps to 6.3 percent. The advanced material segment revenues were 20 percent higher at Rs 338 crore and margins nearly doubled to 13 percent versus 7.6 percent in same quarter of last year.

Lalbhai, while interacting with CNBC-TV18 said there is progress in the advanced materials business and is expected to contribute higher in the company's overall business.

Any uptick in business is not expected before the second half of FY24. Initial two quarters of FY24 are expected to be dull although sequential growth is expected. The advanced materials division is expected to grow above 20 percent in FY24 clocking healthy margins.

The long term debt has reduced to Rs 378 crore in FY23 from Rs 758 crore in FY22. The company is comfortable at current levels of debt and capex shall be funded using internal accruals.

Arvind Ltd stock ended May 18 with 6 percent gains and 36 percent up move since the start of calendar year 2023.

Arvind Ltd is among the largest denim manufacturers in the world. It also manufactures a range of cotton shirting, denim, knits and bottom weights (Khakis) fabrics and Jeans and Shirts Garments.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Imax Poised for Market Share Growth in 2025, Wedbush Says
Imax Poised for Market Share Growth in 2025, Wedbush Says
Sep 3, 2024
09:17 AM EDT, 09/03/2024 (MT Newswires) -- Imax ( IMAX ) is poised for market share gains in 2025 as moviegoers increasingly prefer the company's screens while the theatre company expands its global presence, Wedbush Securities said in a Tuesday client note. The company, which designs and manufactures IMAX ( IMAX ) cameras and projection systems, is gaining market share...
ProKidney Halts 1 Phase 3 Trial of Rilparencel, Says Not Essential for Securing FDA Approval
ProKidney Halts 1 Phase 3 Trial of Rilparencel, Says Not Essential for Securing FDA Approval
Sep 3, 2024
09:20 AM EDT, 09/03/2024 (MT Newswires) -- ProKidney ( PROK ) said Tuesday it will discontinue its PROACT 2 phase 3 trial of rilparencel that focused on enrollment outside the US, believing it is not required for initial US registration. The company said rilparencel, a potential treatment for the preservation of kidney function in type 2 diabetes and advanced chronic...
Why Is Halliburton Stock Falling Today?
Why Is Halliburton Stock Falling Today?
Sep 3, 2024
Halliburton Company’s stock is trading lower on Tuesday in the premarket session. Earlier, in an exchange filing dated August 21, the company said that it became aware that an unauthorized third party gained access to certain of its systems. Halliburton ( HAL ) reported today in a filing that the cyber attack has disrupted and restricted access to critical business...
--Super Micro Computer Doesn't Foresee Material Changes to Q4, Fiscal Year Results Despite Filing Delay
--Super Micro Computer Doesn't Foresee Material Changes to Q4, Fiscal Year Results Despite Filing Delay
Sep 3, 2024
09:16 AM EDT, 09/03/2024 (MT Newswires) -- Price: 435.50, Change: -2.20, Percent Change: -0.50 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved